Depression is one of the most widespread mental health disorders, affecting over 280 million people worldwide. In our country, 5.7% of the population suffers from depression, placing us among the 10 countries with the highest rates worldwide.
Failure to detect depression in a timely manner contributes to the worsening of mental health disorders, making it harder for individuals to engage in treatment and negatively affecting both their personal and social lives.
At BIOIATRIKI Healthcare Group, in collaboration with LANGaware, we offer an innovative, scientifically validated, and user-friendly test for the early detection and monitoring of depression in individuals over the age of 20. By using artificial intelligence and analyzing digital voice and speech biomarkers, LANGaware’s depression test provides individuals with a reliable assessment of their mental health in under 5 minutes, facilitating timely intervention and treatment.
You can have your test either online or in person at our Diagnostic Centers (Polydynamo Diagnostic Center & Alpha Evresis Imaging Diagnostic Center in Nicosia).
Why choose the early detection test for depression:
- Objective & Accurate Diagnosis: The test uses digital voice and speech biomarkers, analyzing characteristics such as rhythm, coherence, word choice, and intonation.
- Immediate and Easy Application: Less than 2 minutes of speaking are required for the analysis and processing of the result.
- Scientifically Proven: The test is based on clinical studies and advanced Artificial Intelligence algorithms.
- Enhanced assessment: Early and accurate diagnosis contributes to personalized treatment.
- Improved psychological care: It enhances the proper therapeutic approach, facilitating immediate intervention.
- One step ahead: It is an innovative tool that enhances the medical evaluation of your treating physician.
The test is offered at a special price:
